Adenocarcinoma

"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant epithelial tumor with a glandular organization.

Descriptor ID	D000230
MeSH Number(s)	C04.557.470.200.025
Concept/Terms	Adenocarcinoma Adenocarcinoma Adenocarcinomas Adenoma, Malignant Adenomas, Malignant Malignant Adenoma Malignant Adenomas Carcinoma, Granular Cell Carcinoma, Granular Cell Carcinomas, Granular Cell Granular Cell Carcinoma Granular Cell Carcinomas Adenocarcinoma, Granular Cell Adenocarcinomas, Granular Cell Granular Cell Adenocarcinoma Granular Cell Adenocarcinomas Adenocarcinoma, Tubular Adenocarcinoma, Tubular Adenocarcinomas, Tubular Tubular Adenocarcinoma Tubular Adenocarcinomas Carcinoma, Tubular Carcinomas, Tubular Tubular Carcinoma Tubular Carcinomas Carcinoma, Cribriform Carcinoma, Cribriform Carcinomas, Cribriform Cribriform Carcinoma Cribriform Carcinomas Adenocarcinoma, Basal Cell Adenocarcinoma, Basal Cell Adenocarcinomas, Basal Cell Basal Cell Adenocarcinoma Basal Cell Adenocarcinomas Adenocarcinoma, Oxyphilic Adenocarcinoma, Oxyphilic Adenocarcinomas, Oxyphilic Oxyphilic Adenocarcinoma Oxyphilic Adenocarcinomas

Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]

Below are MeSH descriptors whose meaning is related to "Adenocarcinoma".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.

Bar chart showing 235 publications over 30 distinct years, with a maximum of 17 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	2	2
1997	1	0	1
1998	1	0	1
1999	1	1	2
2000	1	0	1
2001	2	1	3
2002	4	1	5
2003	3	1	4
2004	3	6	9
2005	10	2	12
2006	12	4	16
2007	10	3	13
2008	15	2	17
2009	9	4	13
2010	10	5	15
2011	13	1	14
2012	12	3	15
2013	13	0	13
2014	8	6	14
2015	11	0	11
2016	5	3	8
2017	9	0	9
2018	8	3	11
2019	6	0	6
2020	3	0	3
2021	3	1	4
2022	4	0	4
2023	2	0	2
2024	1	3	4
2025	3	0	3

Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.

Du K, Zhang X, Qin Y, Ma H, Bing C, Deng S, Chen Y, Qin J, Chang S, Xiao S, Peng L, Xie X, Feng X, Fu X, Wei Y, Fan X, Ashktorab H, Smoot D, Jin Z, Peng Y. MAP3K13-232aa encoded by circMAP3K13 enhances cisplatin-induced pyroptosis by directly binding to IKKa in gastric adenocarcinoma. Cell Death Dis. 2025 Sep 01; 16(1):667.

View in: PubMed
Cruz-Correa M, Xu RH, Moehler M, Oh DY, Kato K, Spigel D, Arkenau HT, Tabernero J, Zimina AV, Bai Y, Shi J, Lee KW, Hirano H, Wyrwicz L, Cid RP, Xu H, Sheng T, Barnes G. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the RATIONALE-305 study. Curr Med Res Opin. 2025 Jun; 41(6):1007-1016.

View in: PubMed
Schmit SL, Loro?a NC, Sobieski D, Matejcic M, Nguyen NT, Hoehn HJ, Diaz DB, Shankar K, Cockman EM, Jean-Baptiste E, Tsai YY, Buchalter RB, Brito K, Wilson R, Coppola D, Fulmer C, Saglam O, Tassielli AF, Beato F, Dai R, Freedman JA, Purrington K, Hu B, Mcgrail D, Gibson H, Jiang K, Mu?oz-Antonia T, Flores I, Gordian E, Oliveras Torres JA, Cheng I, Van Blarigan EL, Felder SI, Sanchez JA, Fleming JB, Siegel EM, Cress D, Thompson P, Stern MC, Teer JK, Figueiredo JC. Building research infrastructure to advance precision medicine in colorectal cancer. JNCI Cancer Spectr. 2025 Apr 30; 9(3).

View in: PubMed
Montalvan-Sanchez EE, Hernandez-Marrero J, Norwood DA, Gonz?lez-Pons M, Dominguez RL, Rodriguez LM, Richmond E, Limburg PJ, Cruz-Correa M, Morgan DR. Establishment of a Mesoamerican-Caribbean South-South Research Platform: Challenges in the Meriva (Curcuminoids) Gastric Cancer Chemoprevention Trial. Cancer Prev Res (Phila). 2024 Dec 03; 17(12):549-555.

View in: PubMed
Gregory MD, Ofosu-Asante K, Lazarte JMS, Puente PE, Tawfeeq N, Belony N, Huang Y, Offringa IA, Lamango NS. Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis. PLoS One. 2024; 19(10):e0312563.

View in: PubMed
Curtis RM, Wang HS, Luo X, Dugo EB, Stevens JJ, Tchounwou PB. Fractionated Leaf Extracts of Ocimum gratissimum Inhibit the Proliferation and Induce Apoptosis of A549 Lung Adenocarcinoma Cells. Nutrients. 2024 Aug 16; 16(16).

View in: PubMed
Govindarajan A, Venter F, Chaudhry A, Kaur H, Cobos E, Petersen G. Colorectal Carcinoma-An Anomalous Trigger of Adult Hemophagocytic Lymphohistiocytosis. J Investig Med High Impact Case Rep. 2024 Jan-Dec; 12:23247096241273131.

View in: PubMed
Lew R, Cheng S, Chun I, Ishikawa K, Ahn HJ, Wai C. Gastric adenocarcinoma location and postoperative complication rates in Asian patients: A 2014-2019 NSQIP analysis. Am J Surg. 2024 01; 227:208-212.

View in: PubMed
Zhang C, Calderon E, Chang YH, Han GR, Kelley SR, Merchea A, Brady JT, Young-Fadok TM, Etzioni DA, Mishra N. Short and long-term oncologic outcomes of patients with colon cancer of the splenic flexure. Am J Surg. 2023 07; 226(1):77-82.

View in: PubMed
Acuna N, Park SY, Le Marchand L, H?bert JR, Boushey C, Wilkens LR, Wu AH, Setiawan VW. Diet quality and risk of gastric adenocarcinoma: The Multiethnic Cohort. Am J Clin Nutr. 2023 01; 117(1):46-54.

View in: PubMed

People

Explore

Similar Concepts

Top Journals